Correction: A novel approach for relapsed/refractory FLT3
mut+
acute myeloid leukaemia: synergistic effect of the combination of bispecific FLT3scFv/NKG2D-CAR T cells and gilteritinib
Mol Cancer
.
2022 Jun 23;21(1):134.
doi: 10.1186/s12943-022-01566-0.
Authors
Ke-Xin Li
#
1
,
Hui-Yang Wu
#
1
,
Wan-Ying Pan
1
,
Meng-Qi Guo
1
,
De-Zhi Qiu
1
,
Yan-Jie He
1
,
Yu-Hua Li
1
,
Dong-Hua Yang
2
,
Yu-Xian Huang
3
Affiliations
1
Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
2
Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY, 11439, USA. yangd1@stjohns.edu.
3
Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China. hyx6610@163.com.
#
Contributed equally.
PMID:
35739513
PMCID:
PMC9219225
DOI:
10.1186/s12943-022-01566-0
No abstract available
Publication types
Published Erratum